Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)
18.57
+0.18 (0.98%)
Aug 20, 2026, 3:04 PM CST
SHE:300534 Revenue
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD had revenue of 231.59M CNY in the quarter ending March 31, 2026, a decrease of -15.69%. This brings the company's revenue in the last twelve months to 843.87M, down -20.56% year-over-year. In the year 2025, Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD had annual revenue of 886.96M, down -14.92%.
Revenue (ttm)
843.87M
Revenue Growth
-20.56%
P/S Ratio
6.68
Revenue / Employee
1.32M
Employees
641
Market Cap
5.63B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 886.96M | -155.55M | -14.92% |
| Dec 31, 2024 | 1.04B | -37.54M | -3.48% |
| Dec 31, 2023 | 1.08B | 280.37M | 35.06% |
| Jan 1, 2023 | 799.68M | 511.87M | 177.85% |
| Jan 1, 2022 | 287.81M | 32.91M | 12.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| HPGC Renmintongtai Pharmaceutical | 10.64B |
| Guizhou Xinbang Pharmaceutical | 5.44B |
| Shanxi Zhendong Pharmaceutical Co.,Ltd | 2.68B |
| Luoxin Pharmaceuticals Group Stock | 2.37B |
| Hunan Warrant Pharmaceutical Co.,Ltd | 1.49B |
| Jinghua Pharmaceutical Group | 1.48B |
| Jiangsu Jibeier Pharmaceutical | 990.68M |
| ChengDu ShengNuo Biotec | 911.15M |